Mast Therapeutics raises $25 million in follow-on

Mast Therapeutics Inc. (NYSE-M:MSTX) raised $25 million through the sale of 50 million units at $0.50 in a follow-on underwritten by Piper Jaffray and Canaccord. Each unit comprises a share and a five...